Passage Bio, Inc.
PASG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $53 | $58 | $63 | $38 |
| Short-Term Investments | $0 | $0 | $0 | $39 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $3 | $3 | $2 |
| Total Curr. Assets | $56 | $60 | $67 | $79 |
| Property Plant & Equip (Net) | $18 | $19 | $19 | $23 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $18 | $19 | $19 | $24 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $74 | $79 | $86 | $102 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $1 | $1 |
| Short-Term Debt | $4 | $4 | $4 | $4 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $18 | $14 | $13 | $15 |
| Total Curr. Liab. | $22 | $20 | $18 | $19 |
| LT Debt | $21 | $21 | $21 | $22 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $21 | $21 | $21 | $22 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $25 | $25 | $25 |
| Total Liabilities | $43 | $41 | $39 | $41 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$692 | -$684 | -$675 | -$659 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $723 | $722 | $721 | $720 |
| Total Equity | $31 | $38 | $47 | $61 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $74 | $79 | $86 | $102 |
| Net Debt | -$28 | -$33 | -$38 | -$12 |